Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

CME Group logoCME Group CME

CME Group said total contract volume in Q2 2025 and the first six months increased compared with the same periods in 2024. The company cited uncertainty surrounding tariffs and Federal Reserve interest rate policy as factors that contributed to the increase in volume.

10-QQuarterly reportFiled Period of report Summary published (UTC)

Key points

AI summary
  1. CME Group said total contract volume in Q2 2025 and the first six months increased compared with the same periods in 2024. The company cited uncertainty surrounding tariffs and Federal Reserve interest rate policy as factors that contributed to the increase in volume.

  2. CME Group said the average rate per contract in Q2 2025 and the first six months declined compared with the same periods in 2024, citing higher volume tier-based incentives and an increase in micro contract volumes as a percentage of total volumes as the primary factors. It added that an increase in the fee structure that went into effect on February 1, 2025 partially offset the overall decreases.

  3. CME Group said earnings from cash performance bond and guaranty fund contributions that are reinvested in Q2 2025 totaled $1,487.6 million, an increase from $1,007.6 million in Q2 2024. The company said expenses related to the distribution of interest earned on collateral reinvestments to clearing firms increased to $1,374.5 million in the same period from $939.4 million.

  4. CME Group said cash and cash equivalents totaled $2.0 billion at June 30, 2025 and $2.9 billion at December 31, 2024. The company said it had no borrowings outstanding under its $2.3 billion multi-currency revolving senior credit facility and had approximately $2.3 billion in excess borrowing capacity.

Key figures

Quarter ended June 30, 2025

Revenue
$1.7B
Operating income
$1.1B
Net income
$1.0B
EPS
$2.81

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Q2 2025 and First Six Months: Market Volatility and Volume

CME Group said total contract volume in Q2 2025 and the first six months increased compared with the same periods in 2024. The company cited uncertainty surrounding tariffs and Federal Reserve interest rate policy as factors that contributed to the increase in volume.

Source · Based on the MD&A text of the filing

Average Rate per Contract Declines

CME Group said the average rate per contract in Q2 2025 and the first six months declined compared with the same periods in 2024, citing higher volume tier-based incentives and an increase in micro contract volumes as a percentage of total volumes as the primary factors. It added that an increase in the fee structure that went into effect on February 1, 2025 partially offset the overall decreases.

Source · Based on the MD&A text of the filing

Reinvestment Earnings and Distribution Expenses

CME Group said earnings from cash performance bond and guaranty fund contributions that are reinvested in Q2 2025 totaled $1,487.6 million, an increase from $1,007.6 million in Q2 2024. The company said expenses related to the distribution of interest earned on collateral reinvestments to clearing firms increased to $1,374.5 million in the same period from $939.4 million.

Source · Based on the MD&A text of the filing

Liquidity and Borrowing Capacity at June 30, 2025

CME Group said cash and cash equivalents totaled $2.0 billion at June 30, 2025 and $2.9 billion at December 31, 2024. The company said it had no borrowings outstanding under its $2.3 billion multi-currency revolving senior credit facility and had approximately $2.3 billion in excess borrowing capacity.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.